RxSight, Inc. (RXST): Price and Financial Metrics


RxSight, Inc. (RXST): $14.92

0.05 (+0.34%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RXST Stock Price Chart Interactive Chart >

Price chart for RXST

RXST Price/Volume Stats

Current price $14.92 52-week high $19.67
Prev. close $14.87 52-week low $8.80
Day low $14.61 Volume 9,964
Day high $15.36 Avg. volume 113,966
50-day MA $13.42 Dividend yield N/A
200-day MA $12.47 Market Cap 410.37M

RxSight, Inc. (RXST) Company Bio


RxSight, Inc., a medical technology company, develops light adjustable lens (LAL) to improve uncorrected visual acuity that can be adjusted enhance uncorrected visual acuity after cataract surgery. It also offers RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is based in Aliso Viejo, California.


RXST Latest News Stream


Event/Time News Detail
Loading, please wait...

RXST Latest Social Stream


Loading social stream, please wait...

View Full RXST Social Stream

Latest RXST News From Around the Web

Below are the latest news stories about RxSight Inc that investors may wish to consider to help them evaluate RXST as an investment opportunity.

RxSight, Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 8, 2022

ALISO VIEJO, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the fourth quarter and fiscal year 2021 after the market close on Tuesday, March 8, 2022. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

GlobeNewswire | February 23, 2022

Rxsight (RXST) Investor Presentation - Slideshow

No summary available.

Seeking Alpha | February 15, 2022

RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference

ALISO VIEJO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual SVB Leerink Global Healthcare Conference. RxSight’s management is scheduled to participate in a fireside chat Thursday, February 17, 2022, at 12:40pm PT / 3:40pm ET. Interested parties may access a live and archived webcast of the presentation on the “Invest

Yahoo | February 3, 2022

RxSight rallies as prelim. revenue for Q4 exceeds estimates

RxSight <> has recorded the biggest intraday gain since its IPO in late July after the company disclosed better than anticipated preliminary unaudited revenue for the final quarter

Seeking Alpha | January 10, 2022

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Financial and Operational Results

ALISO VIEJO, Calif., Jan. 09, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced preliminary unaudited financial and operational results for the fourth quarter and fiscal year 2021. Preliminary Unaudited Results Preliminary unaudited fourth quarter 2021 revenue is expected to be approximately $8.4 million, representing growth of approximately 71% compared to the prio

Yahoo | January 9, 2022

Read More 'RXST' Stories Here

RXST Price Returns

1-mo -9.02%
3-mo 12.69%
6-mo 66.33%
1-year N/A
3-year N/A
5-year N/A
YTD 32.62%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5435 seconds.